1. Introduction {#sec1-biomimetics-04-00047}
===============

Circuits not only allow us to develop complex electronic systems, they also help us in the simulation and modeling of physical systems. The cardiovascular system is one the many examples which can be represented through an electric equivalent system. To set some examples: the heart operates like a hydraulic pump whose blood pressure output behaves like a variable tension source; the heart beats produce sudden shifts in the internal pressure, which makes the tissue in our heart expand as a circuit would react during its transitory phase; veins can be represented electrically as a serial line with complex impedance. Due to these circumstances, the circulatory human system can be represented and simulated by an equivalent electric system.

In this paper, the human heart is simulated alongside some other heart failures. These simulations were implemented in MATLAB/Simulink^®^R2015a using the Cardiovascular Simulation Toolbox (CVST) tool which was originally created by O. Barnea \[[@B1-biomimetics-04-00047]\] and was later updated in Reference \[[@B2-biomimetics-04-00047]\]. Only for a matter of clarity, in this paper, we are calling this updated version of the toolbox CVST-2. This tool has a series of programmed blocks that represent different sections of the circulatory system. To achieve a successful simulation of different heart failures, the obtained values were contrasted with the results of other existing models and medical data gathered in specialized laboratories.

Simulations of the human body can be useful for developing medical equipment, since complex devices such as VAD (Ventricular Assistance Device) or pacemakers could be better developed by taking in account this extra layer of information in their design stages. Tools, such as the one presented in this paper, could benefit the design process by predicting and estimating the human body behavior after a device has been implanted.

Heart failures are caused by a dysfunction of the heart, which denies an adequate blood flow and correct transport of oxygen and nutrients necessary to the metabolism of different tissues \[[@B3-biomimetics-04-00047]\]. They can be divided in two types \[[@B4-biomimetics-04-00047]\]:Depending of the output in the ventricles: "High-Output" and "Low-Output".Depending of their location: "Left-Sided Systolic," "Left-Sided Diastolic" and "Right-Sided Right-Ventricle."

Heart failures could also be explained in terms of their causes and effects. Since it was necessary to observe the effect of different diseases in the cardiovascular system, the model of a healthy condition \[[@B2-biomimetics-04-00047]\] was modified to obtain different failures; this was accomplished due to the ease and flexibility of the programmed blocks of the CVST-2.

2. Simulation Model {#sec2-biomimetics-04-00047}
===================

The CVST-2 tool is a series of programmed blocks which together describes the behavior of the different parts of the cardiovascular system, inside them are a series of electrical connections of different active and passive components, signals and mathematical operations. This tool is divided in five categories:Heart: Contains auricles, ventricles and valves.Measurements: Designed to obtain and visualize different parameters in the system.Veins: Contains power transmission-based circuits.Oxygen Transport: Contains blocks which calculate the oxygen concentration and the gas exchange between blood and the tissues.Other: Groups the other components that don't fit the description of the previous categories, such as resistances and flow valves \[[@B2-biomimetics-04-00047]\].

The complete model sketch of the cardiovascular system in a "healthy condition" can be appreciated in [Figure 1](#biomimetics-04-00047-f001){ref-type="fig"}.

The "healthy condition" refers to the simulation obtained of a healthy person, by using the CVST-2 tool. In addition, this simulation was previously validated by comparing its results with standard medical values of a healthy person \[[@B2-biomimetics-04-00047]\]. This comparison between the simulation and the medical data is shown in [Table 1](#biomimetics-04-00047-t001){ref-type="table"}. Since the simulation values are inside the established limits, this confirms the validity of the simulation for a healthy heart.

Moreover, this tool prints the curves or functions of the different hemodynamic parameters shown in [Table 1](#biomimetics-04-00047-t001){ref-type="table"}. An example of this, which is not explicit in the previous table, is shown in the [Figure 2](#biomimetics-04-00047-f002){ref-type="fig"}, where a P-V loop can be observed. This specific graph allows us to identify a diversity of conditions, such as changes in the elastance, as well as hemodynamic parameters like the Left Ventricular End-Diastolic Volume (LVEDV), Left Ventricular End-Systolic Volume (LVESV) and Left Ventricular Stroke Volume (LVSV), among others \[[@B5-biomimetics-04-00047]\]. With these parameters is possible to determine whether the heart is healthy or presents a failure condition. It should be noted that the data used for the reference values in [Table 1](#biomimetics-04-00047-t001){ref-type="table"}, were obtained from \[[@B6-biomimetics-04-00047],[@B7-biomimetics-04-00047],[@B8-biomimetics-04-00047],[@B9-biomimetics-04-00047],[@B10-biomimetics-04-00047]\].

3. About the Heart Failures {#sec3-biomimetics-04-00047}
===========================

The simulated heart failures presented in this article are the following:High-Output Heart Failure (HOHF): It happens when the body needs high levels of blood, due to that the heart beat faster than usual \[[@B11-biomimetics-04-00047]\]. Causes of HOHF could be: Anemia, hipoertiroidism, arteriovenous fistula, Beriberi illnesses and Paget's in Reference \[[@B12-biomimetics-04-00047]\]. Lobato \[[@B13-biomimetics-04-00047]\] mentions that HOHF is the result of an increase in the diastolic pressure and the volume on the left ventricle. Some effects are: marked vasodilatation, pulse increase, water and salt retention, renal fluid diminution and activation on the neuroendocrine system \[[@B13-biomimetics-04-00047]\]. Also, heart function could be supra normal but this will be inadequate for the high metabolic necessities \[[@B4-biomimetics-04-00047]\].Low-Output Heart Failure (LOHF): It happens due to cardiac disorders that damages the adequate bombing function, due to diastolic and systolic dysfunctions. LOHF can produce damage to the valves, arrhythmia, vasoconstrictions and cyanotic and cold extremities. The cardiac output is normal but it tends to decrease when the body undergoes physical exertion \[[@B4-biomimetics-04-00047]\].Systolic Heart Failure (SHF): It is the heart's incapacity of bombing blood at its normal speed. The ejection fraction in the left ventricle plays an important role when diagnosing it, due to its significant diminution. This is a lethal sickness hence, deaths are very spontaneous \[[@B14-biomimetics-04-00047]\]. Some physical effects are: the cavity of the left ventricle dilates, although the thickness of the wall maintains in a similar way; the contractile function of the heart seems to reduce. Due to that fact, the ejection fraction reduces and so the systolic volume.Diastolic Heart Failure (DHF): It relates with the difficulty of filling one or both ventricles, as also, the camera of the ventricle does not accept the appropriate level of normal blood pressure. In this case, the quantity of blood that is bombed every beat in the left ventricle is normal \[[@B14-biomimetics-04-00047]\]. Some risk factors are: diabetes, hypertension, age, obesity and coronary artery sickness. Physically, the cavity of the left ventricle maintains the same or reduces but on the other hand, the thickness of the wall increases significantly.Right-Ventricle Heart Failure (RVHF): It is a consequence from the damage resulted in the left side of the heart, the increase of blood pressure transfers to the lungs, thus going back to the right side of the heart. The blood accumulates in the veins, each time that the right ventricle loses pumping power. Some effects of RVHF are: inflammations in ankles and legs \[[@B15-biomimetics-04-00047]\].

4. Results {#sec4-biomimetics-04-00047}
==========

The results of different simulations with input values in [Table 2](#biomimetics-04-00047-t002){ref-type="table"}, are shown in [Table 3](#biomimetics-04-00047-t003){ref-type="table"}. This is a comparative table between the output of the different parameters in the conditions previously described and the healthy condition.

Moreover, the graphs of P-V loops will be shown for a further and more extensive comprehension of the simulated conditions. This type of graph helps us describe the behavior of the heart such as its effectiveness to pump blood and the internal efforts, among other characteristics. [Figure 3](#biomimetics-04-00047-f003){ref-type="fig"} shows the P-V loop of the HOHf simulation in the CVST-2; similarly, [Figure 4](#biomimetics-04-00047-f004){ref-type="fig"} shows in the same axes the P-V loop of the LOHF simulation.

It should be noted, that depending of each simulation the curve in the graph shows displacements in the horizontal axis, which represents the amount of blood in the chamber. Also, the increase or decrease in height represents the rise or fall of pressure; which is also useful to describe health conditions in patients. For the first two graphs, although the curve stays centered between the volumes of 80 mL and 180 mL; we can see that each one has a different height, which means that the simulations predict conditions of high and low pressure.

[Figure 5](#biomimetics-04-00047-f005){ref-type="fig"} shows the P-V loop of the SHF simulation; [Figure 6](#biomimetics-04-00047-f006){ref-type="fig"} shows the same type of curve and in the same axes used before for the DHF simulation. Finally, [Figure 7](#biomimetics-04-00047-f007){ref-type="fig"} shows the P-V loop for the RVHF simulation. The conditions showed in the three previous graphs, shows that the curves are moved along the horizontal axis; this indicate that the simulations are related to conditions in which the structure of the heart (wall's thickness and chamber's cavities) could be altered.

5. Discussion {#sec5-biomimetics-04-00047}
=============

Given the results shown in the previous section, we analyzed the data and compared each simulation with the general characteristics, as well as some parameters from different authors, to evaluate if the simulated condition is representative of each heart failure.

HOHF: As shown in [Figure 3](#biomimetics-04-00047-f003){ref-type="fig"}, there's a displacement to the right of the P-V loop curve, which indicates a raise of the volume in the left ventricle of the heart. In addition, the increase in pressure of curve represents a condition of exertion in the heart muscles, therefore, there's an expected higher output of blood. This is demonstrated by the data shown in [Table 2](#biomimetics-04-00047-t002){ref-type="table"}, where the CO and HB increase relative to the healthy condition; both conditions are typical in this type of failure. Furthermore, the expected values for the cardiac output and heart beats are around 8 L/min \[[@B16-biomimetics-04-00047]\] and between 85 and 105 bpm \[[@B17-biomimetics-04-00047]\]; in both cases, the values are approximately the same which demonstrates a consequent behavior with failure description.

LOHF: In [Figure 4](#biomimetics-04-00047-f004){ref-type="fig"}, there's a light displacement of the curve of approximately 10 mL to the right, as well as a beat pressure diminution compared to the one shown in [Figure 2](#biomimetics-04-00047-f002){ref-type="fig"}. This condition indicates that, even though there's a raise in volume, the heart suffers from a deficiency in the force excelled to pump blood correctly. Can also be observed in the output values of [Table 2](#biomimetics-04-00047-t002){ref-type="table"}; this phenomenon in addition to the HB decrease, proves that the simulation has the same general characteristics as the description of the LOHF.

SHF: In the P-V loop curve shown in [Figure 5](#biomimetics-04-00047-f005){ref-type="fig"} a significantly increase in volume in the left ventricle can be observed, as well as a decrease in pressure. These characteristics are caused by exhaustion in the heart chamber's walls, which cause a bigger cavity and lower pressure due to the thinness of the walls \[[@B14-biomimetics-04-00047]\]. Additionally, some of the characteristic values for this failure are: LVEDV of 192 ± 10 mL, LVESV of 137 ± 9 mL and LVEF of 31 ± 2% \[[@B14-biomimetics-04-00047]\], in the [Table 2](#biomimetics-04-00047-t002){ref-type="table"}, these values are respectively: LVEDV is 180.98 mL, LVESV is 136.54 mL and LVEF is 24.55%. With these values and the characteristics of the P-V loop, there's enough evidence to that the general behavior of the simulation is similar to the description of SHF.

DHF: In [Figure 6](#biomimetics-04-00047-f006){ref-type="fig"}, the P-V loop shows a displacement to the left, which traduces to less volume in the ventricle relative to the healthy condition; this movement alongside the decrease pressure in the curve produces a reduction of the CO, as it is shown in the [Table 2](#biomimetics-04-00047-t002){ref-type="table"}. As mentioned in Reference \[[@B14-biomimetics-04-00047]\], this condition is caused by the thickening of the heart walls, which reduces its pumping capacity and its maximum blood volume. In addition, some theoretical range values for the hemodynamic parameters are presented in Reference \[[@B14-biomimetics-04-00047]\]: LVEDV of 87 ± 10 mL, LVESV of 37 ± 9 mL and LVEF of 60 ± 2%. In the [Table 2](#biomimetics-04-00047-t002){ref-type="table"}, these variables have a value of: LVEDV 95.97 mL, LVESV 45.71 mL and LVEF 52.36%; which then again, proves that the simulation for this heart failure is successfully represented.

RVHF: In [Figure 7](#biomimetics-04-00047-f007){ref-type="fig"}, the decrease in the pumping pressure for the systolic phase, reflects the reduction of the CO shown in [Table 2](#biomimetics-04-00047-t002){ref-type="table"}. In addition, this table shows the average reduction of the right ventricle pressure, which is an important characteristic of this type of failure. It should be noted that with the information presented, the damage in the right ventricle also affects the other parts of the heart and the behavior is similar to the description given in Reference \[[@B15-biomimetics-04-00047]\].

6. Input Parameters {#sec6-biomimetics-04-00047}
===================

Most heart failures produce damages such as the thickening of heart walls, diminution of the heart chamber's contraction, reduction of the elastic tissues walls and increments of the heart valve's resistance. These effects are meaningful in the simulation of heart failures, since those are a starting point in determining the input parameters values.

The modifications for the simulation model variables are shown in [Table 3](#biomimetics-04-00047-t003){ref-type="table"}. Among the variables changes, it can be noted that the heart beat adjusts between the failures, as the description suggests. The chamber's elastance was changed to represent damage or loss of elasticity in the tissues. Moving along these lines, the resistance of the valves and the initial volume were changed to affect the ejection fraction. It should be stressed, that these changes followed the description given before of each condition.

7. Conclusions {#sec7-biomimetics-04-00047}
==============

The CVST-2 tool, not only provides an adequate simulation of the hemodynamic parameters of a healthy person but it also allows the simulation of the heart conditions due to different failures. Due to the ease of these parameter's manipulation, we achieved, through simulation, the general behavior of five different heart failures. With this, we can provide a more precise description of the heart's behavior to study in vitro the effect of adding different devices or components in the cardiovascular system, such as artificial cardiac pacemaker or a ventricular assist device. It should be also noted that this tool provides help for students in the biological area, as they can see and manipulate a heart's condition in a simulation, instead of having to look for records of previous patients. Which gives this tool a great importance in development of medical devices as well for academic purposes.
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The following abbreviations are used in this manuscript:

HB

Heart Beat

CO

Cardiac Output

LVEDV

Left Ventricle End-Diastolic Volume

LVESV

Left Ventricle End-Systolic Volume

LVSV

Left Ventricle Stroke Volume

CVST

Cardiovascular Simulation Toolbox

HOHF

High Output Heart Failure

LOHF

Low Output Heart Failure

SHF

Systolic Heart Failure

DHF

Diastolic Heart Failure

RVHF

Right Ventricle Heart Failure
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biomimetics-04-00047-t001_Table 1

###### 

Comparison of hemodynamic parameters between a healthy person and the Cardiovascular Simulation Tool (CVST-2) simulation.

  Parameter                    Units   Reference Value                                Normal     
  ---------------------------- ------- ---------------------------------------------- ---------- ----------
  Heart Rate                   bpm     48--105 \[[@B6-biomimetics-04-00047]\]         75         \-
  Cardiac output               L/min   4.0--8.0 \[[@B6-biomimetics-04-00047]\]        6.7154     \-
  Left Ventricular Volume      mL      16--239 \[[@B7-biomimetics-04-00047]\]         62.5976    152.1365
  Right Ventricular Volume     mL      50--160 \[[@B6-biomimetics-04-00047]\]         78.7093    152.6721
  Left Atrial Volume           mL      25.3--109.7 \[[@B9-biomimetics-04-00047]\]     19.3332    102.0856
  Right Atrial Volume          mL      26.4--121.5 \[[@B9-biomimetics-04-00047]\]     7.3287     79.7041
  Arterial Pressure            mmHg    60--140 \[[@B10-biomimetics-04-00047]\]        68.47      144.3845
  Left Ventricular Pressure    mmHg    0--140 \[[@B10-biomimetics-04-00047]\]         1.8499     147.8072
  Left Atrial Pressure         mmHg    4.0--12 \[[@B6-biomimetics-04-00047]\]         0.4368     30.1822
  Right Ventricular Pressure   mmHg    2.0--30 \[[@B6-biomimetics-04-00047]\]         2.1612     41.7744
  Right Atrial Pressure        mmHg    2.0--6.0 \[[@B6-biomimetics-04-00047]\]        0.2426     21.4079
  LV Stroke Volume             mL      60--100 \[[@B6-biomimetics-04-00047]\]         89.5389    \-
  RV Stroke Volume             mL      60--100 \[[@B6-biomimetics-04-00047]\]         73.9628    \-
  LV End-Diastolic Volume      mL      120 (65--239) \[[@B8-biomimetics-04-00047]\]   152.1365   \-
  LV End-Systolic Volume       mL      50 (16--143) \[[@B8-biomimetics-04-00047]\]    62.5976    \-
  RV End-Diastolic Volume      mL      100--160 \[[@B6-biomimetics-04-00047]\]        152.6721   \-
  RV End-Systolic Volume       mL      50--100 \[[@B6-biomimetics-04-00047]\]         78.7093    \-
  LV Ejection Fraction         \%      59.9 (18--76) \[[@B8-biomimetics-04-00047]\]   58.8543    \-
  RV Ejection Fraction         \%      40--60 \[[@B6-biomimetics-04-00047]\]          48.4455    \-

biomimetics-04-00047-t002_Table 2

###### 

Values of the input variables for the simulation of different conditions.

  Variable                          Normal   SHF     RVHF    LOHF    HOHF    DHF
  --------------------------------- -------- ------- ------- ------- ------- -------
  Heart Rate                        75       75      75      65      100     75
  LV Emax                           2.5      1       2.8     2       2.9     2.5
  LV P-V graph intercepted volume   15       60      15      15      50      15
  LV End-Diastolic Volume           112      137     120     112     132     112
  MV Resistance                     0.02     0.05    0.03    0.02    0.03    0.05
  AV Resistance                     0.002    0.005   0.003   0.006   0.008   0.005
  RV Emax                           0.85     0.35    0.3     0.85    0.85    0.85
  RV P-V graph intercepted volume   50       60      50      50      50      50
  RV Initial Volume                 80       65      80      80      80      80
  TV Resistance                     0.02     0.05    0.03    0.03    0.03    0.05
  PV Resistance                     0.002    0.005   0.008   0.004   0.003   0.005
  LA Emax                           1        0.8     1       1       1       0.8
  LA BFR                            0.1      0.15    0.1     0.1     0.1     0.15
  RA Emax                           1        0.8     1       1       1       0.8
  RA BFR                            0.1      0.2     0.1     0.1     0.1     0.2

biomimetics-04-00047-t003_Table 3

###### 

Output hemodynamic values for different heart failures in the CVST-2.

  Parameter   Units                                    Normal   SHF        RVHF       LOHF       HOHF       DHF                                                                          
  ----------- ---------------------------------------- -------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
  HR          Heart Rate                               bpm      75         \-         75         \-         75         \-         65         \-         100        \-         75         \-
  CO          Cardiac output                           L/min    6.7154     \-         3.3494     \-         5.5054     \-         5.879      \-         7.0117     \-         3.7728     \-
  LVV         Left Ventricular Volume                  mL       62.5976    152.1365   135.793    180.4515   50.9441    124.3494   70.7789    161.2252   90.635     160.7519   45.439     95.7433
  RVV         Right Ventricular Volume                 mL       78.7093    152.6721   117.8721   156.0561   128.5198   189.2988   78.5933    154.2769   77.3493    134.5208   74.253     115.8001
  LAV         Left Atrial Volume                       mL       19.3332    102.0856   27.195     83.431     18.7101    93.7377    20.826     114.4978   16.2727    80.9615    29.0205    84.0079
  RAV         Right Atrial Volume                      mL       7.3287     79.7041    11.3458    50.6052    11.3257    82.8504    9.0201     89.2757    6.2522     62.3506    9.909      50.3329
  AP          Arterial Pressure                        mmHg     68.47      144.3845   44.4787    81.3584    59.2085    122.4431   60.1552    129.1583   75.4493    146.3819   46.3871    89.3429
  LVP         Left Ventricular Pressure                mmHg     1.8499     147.8072   7.9626     84.8965    1.3463     126.253    2.243      134.5208   3.4325     154.4136   1.1235     93.3702
  LAP         Left Atrial Pressure                     mmHg     0.4368     30.1822    0.5485     35.1587    0.4093     31.3536    0.4849     37.0309    0.3594     31.2227    0.5907     36.8683
  RVP         Right Ventricular Pressure               mmHg     2.1612     41.7744    4.5958     30.7118    5.5388     37.0351    2.1566     41.3696    2.0972     41.3268    1.961      33.6142
  RAP         Right Atrial Pressure                    mmHg     0.2426     21.4079    0.2441     21.5873    0.2674     28.7435    0.2673     26.1614    0.1876     23.3241    0.2349     19.7209
  LVSV        Left Ventricular Stroke Volume           mL       89.5389    \-         44.6585    \-         73.4053    \-         90.4463    \-         70.117     \-         50.3043    \-
  RVSV        Right Ventricular Stroke Volume          mL       73.9628    \-         38.184     \-         60.779     \-         75.6836    \-         57.1715    \-         41.5471    \-
  LVEDV       Left Ventricular End-Diastolic Volume    mL       152.1365   \-         180.4515   \-         124.3494   \-         161.2252   \-         160.7519   \-         95.7433    \-
  LVESV       Left Ventricular End-Systolic Volume     mL       62.5976    \-         135.793    \-         50.9441    \-         70.7789    \-         90.635     \-         45.439     \-
  RVEDV       Right Ventricular End-Diastolic Volume   mL       152.6721   \-         156.0561   \-         189.2988   \-         154.2769   \-         134.5208   \-         115.8001   \-
  RVESV       Right Ventricular End-Systolic Volume    mL       78.7093    \-         117.8721   \-         128.5198   \-         78.5933    \-         77.3493    \-         74.253     \-
  LVEF        Left Ventricular Ejection Fraction       \%       58.8543    \-         24.7482    \-         59.0315    \-         56.0993    \-         43.6181    \-         52.5409    \-
  RVEF        Right Ventricular Ejection Fraction      \%       48.4455    \-         24.4681    \-         32.1075    \-         49.057     \-         42.5001    \-         35.8783    \-

[^1]: These authors contributed equally to this work.
